Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Pacific Biosciences of California, Inc. (NASDAQ:PACB) represented a move of 1.04 percent or $-0.1 per share and closed its previous day trading session at $7.8. 7.23 Million Shares were traded in the last trading session with an Average Volume of 3.23 Million Shares. The stock currently has a Market Capitalization of 679.38 Million.
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company’s technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
The stock traded between $2.02 and $7.84 over 1-Year time period showing its price to sales ratio of 8.09. Pacific Biosciences of California, Inc. (NASDAQ:PACB) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $60.06 and 200-Day Simple Moving Average of $123.43. Its Price to Free Cash Flow is 0 and Price to Book of 12.
Analyst’s recommended the stock as 2.4 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Pacific Biosciences of California, Inc. (NASDAQ:PACB) reported its Actual EPS of $-0.19/share. The analysts offering Earnings Estimates for the company were believing that Pacific Biosciences of California, Inc. could bring EPS of $-0.15/share. The difference between Actual EPS and Estimated EPS was -0.04 Percent. Thus showing an Earnings Surprise of -26.7 Percent.
Goldcorp Inc. (NYSE:GG)
In the last trading session, Goldcorp Inc. (NYSE:GG) added its value by 0.54% closing at the price of $9.38. The stock currently has market capitalization of 8.15 Billion, with average volume of 10.06 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Goldcorp Inc. (NYSE:GG) is showing beta of 0.16. This particular value of beta suggests that Goldcorp Inc. (NYSE:GG) has historically moved 16% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Goldcorp Inc. (NYSE:GG) is at $0.09.
The stock currently has RSI of 42.18. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Goldcorp has operations in Canada, the US, Mexico and Central and South America. Apart from gold, the company also produces copper and silver. The company’s principal producing mining properties are the Red Lake, Porcupine and Musselwhite gold mines in Canada The Penasquito gold/silver/zinc/lead mine, the Pueblo Viejo gold mine (40% interest) in the Dominican Republic, the Los Filos and El Sauzal gold mines in Mexico the Marlin gold/silver mine in Guatemala the Alumbrera gold/copper mine (37.5% interest) in Argentina and the Marigold (66.7% interest) and Wharf gold mines in the United States. Goldcorp has significant development projects which include the Cerro Negro gold project in Argentina l onore and Cochenour gold projects in Canada, the El Morro gold/copper project (70% interest) in Chile and the Camino Rojo gold/silver projects in Mexico.
Goldcorp Inc. (NYSE:GG) topped its 52-week high price of $15.55 on 01/16/18 and 52-Week Low Price of $ 8.42 on 10/25/18. The Stock currently has P/E (price to earnings ttm) of 107.82 and Weekly volatility of 2.70% and monthly volatility of 4.52% respectively.